lenalidomide has been researched along with Leukemia, Prolymphocytic, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q; Li, Z; Wang, H; Xie, L; Xing, L | 1 |
1 review(s) available for lenalidomide and Leukemia, Prolymphocytic, B-Cell
| Article | Year |
|---|---|
Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Lenalidomide; Leukemia, Prolymphocytic, B-Cell; Piperidines; Pyrazoles; Pyrimidines; Rituximab; Tumor Suppressor Protein p53 | 2022 |